These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23837070)

  • 1. The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats.
    Zhao J; Yu QX; Kong W; Gao HC; Sun B; Xie YQ; Ren LQ
    Exp Ther Med; 2013 Jun; 5(6):1765-1769. PubMed ID: 23837070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urotensin receptor antagonist urantide improves atherosclerosis-related kidney injury by inhibiting JAK2/STAT3 signaling pathway in rats.
    Wang T; Xie YQ; Miao GX; Cui HP; Liu K; Li Y; Li Y; Zhao J
    Life Sci; 2020 Apr; 247():117421. PubMed ID: 32061865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urantide decreases hepatic steatosis in rats with experimental atherosclerosis via the MAPK/Erk/JNK pathway.
    Cui H; Lin Y; Xie L; Zhao J
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urantide attenuates myocardial damage in atherosclerotic rats by regulating the MAPK signalling pathway.
    Zhao J; Miao G; Wang T; Li J; Xie L
    Life Sci; 2020 Dec; 262():118551. PubMed ID: 33038370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peptide compound urantide regulates collagen metabolism in atherosclerotic rat hearts and inhibits the JAK2/STAT3 pathway.
    Wang T; Sun X; Cui H; Liu K; Zhao J
    Mol Med Rep; 2020 Mar; 21(3):1097-1106. PubMed ID: 32016456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
    Wang ZJ; Ding WH; Shi LB; Bu DF; Ren ZW; Tang CS
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):242-6. PubMed ID: 16677503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits.
    Yu QQ; Cheng DX; Xu LR; Li YK; Zheng XY; Liu Y; Li YF; Liu HL; Bai L; Wang R; Fan JL; Liu EQ; Zhao SH
    Acta Pharmacol Sin; 2020 Apr; 41(4):546-553. PubMed ID: 31685976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urantide alleviates the symptoms of atherosclerotic rats in vivo and in vitro models through the JAK2/STAT3 signaling pathway.
    Wang T; Xie L; Bi H; Li Y; Li Y; Zhao J
    Eur J Pharmacol; 2021 Jul; 902():174037. PubMed ID: 33891969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of urotensin II and its specific receptor antagonist urantide on rat vascular smooth muscle cells.
    Zhao J; Zhang SF; Shi Y; Ren LQ
    Bosn J Basic Med Sci; 2013 May; 13(2):78-83. PubMed ID: 23725502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urotensin II contributes to collagen synthesis and up-regulates Egr-1 expression in cultured pulmonary arterial smooth muscle cells through the ERK1/2 pathway.
    Li W; Cai Z; Liu M; Zhao C; Li D; Lv C; Wang Y; Xu T
    Biochem Biophys Res Commun; 2015 Nov; 467(4):1076-82. PubMed ID: 26431877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urotensin II-induced collagen synthesis in cultured smooth muscle cells from rat aortic media and a possible involvement of transforming growth factor-β1/Smad2/3 signaling pathway.
    Zhao J; Ding W; Song N; Dong X; Di B; Peng F; Tang C
    Regul Pept; 2013 Mar; 182():53-8. PubMed ID: 23403244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues.
    Zeng ZP; Liu GQ; Li HZ; Fan XR; Liu DM; Tong AL; Zheng X; Liu C
    Ann N Y Acad Sci; 2006 Aug; 1073():284-9. PubMed ID: 17102097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UII/GPR14 is involved in NF-κB-mediated colonic inflammation in vivo and in vitro.
    Yang Y; Zhang J; Chen X; Wu T; Xu X; Cao G; Li H; Li Y
    Oncol Rep; 2016 Nov; 36(5):2800-2806. PubMed ID: 27600191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urantide prevents CCl4‑induced acute liver injury in rats by regulating the MAPK signalling pathway.
    Li Y; Guo Z; Cui H; Wang T; Xu Y; Zhao J
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.
    Liu Q; Pong SS; Zeng Z; Zhang Q; Howard AD; Williams DL; Davidoff M; Wang R; Austin CP; McDonald TP; Bai C; George SR; Evans JF; Caskey CT
    Biochem Biophys Res Commun; 1999 Dec; 266(1):174-8. PubMed ID: 10581185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of urotensin II receptor antagonist urantide and exercise training on doxorubicin-induced cardiotoxicity.
    Sun J; Zhou J; Sun S; Lin H; Zhang H; Zhong Z; Chi J; Guo H
    Sci Rep; 2023 Jan; 13(1):1279. PubMed ID: 36690700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of the urotensin II receptor in the rat central nervous system.
    Jégou S; Cartier D; Dubessy C; Gonzalez BJ; Chatenet D; Tostivint H; Scalbert E; LePrince J; Vaudry H; Lihrmann I
    J Comp Neurol; 2006 Mar; 495(1):21-36. PubMed ID: 16432902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat.
    Gong H; Wang YX; Zhu YZ; Wang WW; Wang MJ; Yao T; Zhu YC
    J Appl Physiol (1985); 2004 Dec; 97(6):2228-35. PubMed ID: 15273242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Urotensin II During Focal Cerebral Ischemic in Diabetic Rats.
    Tian L; Li Y; Hua W; Jia Y; Zhou M; Gu Y; Qi J
    Can J Neurol Sci; 2014 Jul; 41(4):498-503. PubMed ID: 24878476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between vasoactive peptide urotensin II in plasma and cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a potential therapeutic target.
    Clavier T; Mutel A; Desrues L; Lefevre-Scelles A; Gastaldi G; El Amki M; Dubois M; Melot A; Wurtz V; Curey S; Gérardin E; Proust F; Compère V; Castel H
    J Neurosurg; 2019 Oct; 131(4):1278-1288. PubMed ID: 30497195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.